346 related articles for article (PubMed ID: 11704632)
1. COX-2 and cancer: a new approach to an old problem.
Bakhle YS
Br J Pharmacol; 2001 Nov; 134(6):1137-50. PubMed ID: 11704632
[No Abstract] [Full Text] [Related]
2. The molecular perspective: cyclooxygenase-2.
Goodsell DS
Oncologist; 2000; 5(2):169-71. PubMed ID: 10794808
[No Abstract] [Full Text] [Related]
3. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
Rao M; Yang W; Seifalian AM; Winslet MC
Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
[TBL] [Abstract][Full Text] [Related]
4. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.
Serhan CN; Oliw E
J Clin Invest; 2001 Jun; 107(12):1481-9. PubMed ID: 11413151
[No Abstract] [Full Text] [Related]
5. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
6. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
7. The prevention of colorectal cancer by aspirin use.
Giovannucci E
Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
[TBL] [Abstract][Full Text] [Related]
8. [Nonsteroidal anti-rheumatic drugs and colon carcinoma: COX versus PPAR].
Wächtershäuser A; Stein J
Z Gastroenterol; 1999 Mar; 37(3):257-61. PubMed ID: 10234800
[No Abstract] [Full Text] [Related]
9. COX-2 in large bowel cancer: a one-sided story.
DuBOIS RN
Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
[No Abstract] [Full Text] [Related]
10. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and the prevention of colorectal cancer.
Berman KS
N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
[No Abstract] [Full Text] [Related]
12. Selective cyclooxygenase-2 inhibition: biological and clinical effects.
Conti F; Spinelli FR; Ossandon A; Valesini G
Isr Med Assoc J; 2000 Nov; 2(11):841-7. PubMed ID: 11344755
[No Abstract] [Full Text] [Related]
13. Aspirin and salicylate: An old remedy with a new twist.
Wu KK
Circulation; 2000 Oct; 102(17):2022-3. PubMed ID: 11044413
[No Abstract] [Full Text] [Related]
14. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
16. Colorectal cancer and non-steroidal anti-inflammatory drugs.
Ota S; Bamba H; Kato A
Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
[TBL] [Abstract][Full Text] [Related]
17. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.
Bertagnolli MM
J Surg Oncol; 2003 Nov; 84(3):113-9. PubMed ID: 14598353
[No Abstract] [Full Text] [Related]
18. The role of prostaglandin synthesis in prostate cancer.
Badawi AF
BJU Int; 2000 Mar; 85(4):451-62. PubMed ID: 10691825
[No Abstract] [Full Text] [Related]
19. New strategies for colorectal cancer prevention and treatment.
Saha D; Roman C; Beauchamp RD
World J Surg; 2002 Jul; 26(7):762-6. PubMed ID: 11948369
[TBL] [Abstract][Full Text] [Related]
20. COX-2 and colorectal cancer.
Ferrández A; Prescott S; Burt RW
Curr Pharm Des; 2003; 9(27):2229-51. PubMed ID: 14529404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
